AstraZeneca India gets CDSCO approval for additional indication for Osimertinib in unresectable…
The approval follows evidence from the Phase III LAURA trial, which demonstrated significant clinical benefits in delaying disease…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.